Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?
Bosch
Jaime
J
Liver Unit, Hospital Clínic, University of Barcelona, Spain. jbosch@medicina.ub.es
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001706:Biopsy; D018450:Disease Progression; D016099:Endoscopy, Gastrointestinal; D004932:Esophageal and Gastric Varices / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications; D008103:Liver Cirrhosis / Q000150:complications* / Q000473:pathology; D008875:Middle Aged; D009248:Nadolol / Q000627:therapeutic use*; D016037:Single-Blind Method; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D009248:Nadolol